Good MorningThe broad S&P 500 index advanced another 2.0% on Thursday bringing the rally to four days. The move is seemingly inexplicable with so much uncertainty in the air but may come down to one thing. Where the market is concerned, a Biden victory and Republican senate is the best-case scenario for the economy. With this outcome, it is all but assured there will be no major changes at the Federal level until after the mid-term election cycle at least.
In other news, the FOMC decided to hold interest unchanged and made no move to alter existing stimulus efforts. Fed Cheif Jerome Powell says the economy is rebounding but still well below the pre-COVID levels. He says the committee is closely watching the data and is prepared to act if needed. In his word, the Fed is not out of ammunition yet.
Featured: Historic Refi Rate: 2.28% APR (15 year) (LendingTree) 
|
Stocks | | | it appears that ridesharing, sports betting, and cannabis companies might be in for some upside going forward. 3 stocks in those respective industries look like solid buys at this time. Let’s take a deeper look at them below. Read the Full Story |
|
|
Politics | | | U.S. futures and world shares surged on Thursday as investors awaited the outcome of the U.S. presidential election and embraced the upside of more gridlock in Washington.
European markets opened higher after a day of gains in Asia, while the fate of the U.S. presidency remained unde... Read the Full Story |
|
Markets | | | Chinese leaders are conducting an import fair under intensive anti-coronavirus controls in their latest effort to revive the world’s No. 2 economy while the United States and Europe struggle with a renewed surge of infections Read the Full Story |
|
|
Politics | | | The Bank of England has increased its monetary stimulus by a bigger than anticipated 150 billion pounds ($195 billion) as it tries to boost the economy through new lockdown measures.
In a statement released Thursday, the bank's rate-setting panel warned that the economy is set for ano... Read the Full Story |
|
Markets | | | As COVID-19 cases keep rising, the European Union's executive commission lowered its forecast for the economic rebound from the coronavirus pandemic next year and said the economy wouldn’t reach pre-virus levels until 2023.
The regular autumn forecast foresees growth of only 4.2% in 2... Read the Full Story |
|
From Our PartnersLendingTree has helped over 1.1 million Americans with refinancing. Calculate your payment to see how much you can save. | | | | Continue Reading |
|
Markets | | | Indonesia’s economy has fallen into recession for the first time since the Asian financial crisis more than two decades ago as the country struggles to control the coronavirus pandemic.
Statistics Indonesia, the central statistics agency, said Thursday that Southeast Asia’s largest e... Read the Full Story |
|
Markets | | | Social media platform Snap Inc. (NASDAQ: SNAP) shares have exploded to the upside since our article on March 25, 2020, suggested buying shares in the single digits on pullbacks. We unveiled the powerful pandemic tailwinds that could trigger a breakout for prudent investors. Snap has transformed itse... Read the Full Story |
|
Markets | | | A Specialty Dividend For Dividend Growth Investors
I am well aware of the trends within the consumer food group so I am not surprised by what I see in Lancaster Colony Corporation’s (NASDAQ:LANC) fiscal Q1 report. What I am surprised about is that I have never heard of this company and I wish... Read the Full Story |
|
Markets | | | Cardinal Health Pops After Q3 Earnings
I like Cardinal Health (NYSE:CAH) for many reasons but there are a few that stand out. The first is that Cardinal Health is a great dividend-payer in the health care field. The second is that Cardinal Health is part of what I like to call the infrastructure of... Read the Full Story |
|
Markets | | | Papa John’s (NASDAQ:PZZA) alone saw revenue jump 15% in the 2nd quarter, well above consensus, and those trends have not played out. If the 3rd quarter results are any evidence, revenue growth at Papa Johns is still accelerating. Read the Full Story |
|
The Early Bird Stock Of The Day ARCA biopharma, Inc., a clinical stage biopharmaceutical company, engages in the development and commercialization of targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with heart failure. It is developing Recombinant Nematode Anticoagulant Protein c2, a protein therapeutic that is in Phase IIb clinical trial for the treatment for COVID-19. The company has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial. ARCA biopharma, Inc. is headquartered in Westminster, Colorado. | | View Today's Stock Pick |
|
